The most common side effects are gastrointestinal: nausea, vomiting, diarrhoea, and constipation, particularly during the early dose-escalation phase
If you have kidney disease or other health conditions, personalised dietary advice from a dietitian may be beneficial
Almost everyone who tries a product will come back for more
Further developments include the introduction of drugs with dual GIP and GLP-1 agonism, such as tirzepatide, as well as research into incretin agonists that also modulate the glucagon pathway [16, 88, 101]
It involves more recovery time and carries higher risks compared to other methods
The combination is used in functional medicine settings where physicians supervise both compounds together